Park Jimin, Lee Daeun, Seo Eun Kyoung, Ryu Jae-Sang, Shin Dong Hae
Department of Pharmacy, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Global Top 5 Research Program, Ewha W. University, Seoul, 03760, Republic of Korea.
Appl Microbiol Biotechnol. 2017 Jun;101(11):4521-4532. doi: 10.1007/s00253-017-8148-1. Epub 2017 Mar 9.
The ADP-L-glycero-β-D-manno-heptose and the GDP-6-deoxy-α-D-manno-heptose biosynthesis pathways play important roles in constructing lipopolysaccharide of Gram-negative bacteria. Blocking the pathways is lethal or increases antibiotic susceptibility to pathogens. Therefore, the enzymes involved in the pathways are novel antibiotic drug targets. Here, we designed an efficient method to assay the whole enzymes in the pathways using mass spectrometry and screened 148 compounds. One promising lead is (-)-nyasol targeting D-glycero-α-D-manno-heptose-1-phosphate guanylyltransferase (HddC) included in the GDP-6-deoxy-α-D-manno-heptose biosynthesis pathway from Burkholderia pseudomallei. The inhibitory activity of the lead compound against HddC has been confirmed by blocking the system transferring the guanosine monophosphate (GMP) moiety to α-D-glucose-1-phosphate. (-)-Nyasol exhibits the half maximal inhibitory concentration (IC50) value of 17.6 μM. A further study is going on using (-)-nyasol derivatives to find better leads with high affinity.
ADP-L-甘油-β-D-甘露庚糖和GDP-6-脱氧-α-D-甘露庚糖生物合成途径在革兰氏阴性菌脂多糖的构建中发挥重要作用。阻断这些途径对病原体具有致死性或可增加其对抗生素的敏感性。因此,参与这些途径的酶是新型抗生素药物靶点。在此,我们设计了一种利用质谱分析该途径中所有酶的高效方法,并筛选了148种化合物。一种有前景的先导化合物是(-)-尼亚索尔,它靶向来自类鼻疽伯克霍尔德菌的GDP-6-脱氧-α-D-甘露庚糖生物合成途径中的D-甘油-α-D-甘露庚糖-1-磷酸鸟苷酰转移酶(HddC)。通过阻断将鸟苷单磷酸(GMP)部分转移至α-D-葡萄糖-1-磷酸的系统,已证实该先导化合物对HddC具有抑制活性。(-)-尼亚索尔的半数最大抑制浓度(IC50)值为17.6 μM。目前正在使用(-)-尼亚索尔衍生物进行进一步研究,以寻找具有高亲和力的更好的先导化合物。